Suvretta Capital Management’s Sana Biotechnology SANA Stock Holding History

Suvretta Capital Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,606,056	Closed	-$6.55M	–	113
2023 Q4	$6.55M	Sell	1,606,056 -1,357,648	-46%	-$5M	0.3%	52
2023 Q3	$11.5M	Buy	2,963,704 +849,904	+40%	+$4.57M	0.62%	42
2023 Q2	$12.6M	Hold	2,113,800	–	–	0.67%	48
2023 Q1	$6.91M	Buy	+2,113,800	New	+$8.45M	0.33%	56
2021 Q3	–	Sell	-100,000	Closed	-$1.97M	–	124
2021 Q2	$1.97M	Sell	100,000 -567,500	-85%	-$12.9M	0.03%	111
2021 Q1	$22.3M	Buy	+667,500	New	+$21.7M	0.33%	55

Other funds holding SANA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Canada Pension Plan Investment Board

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return